Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: Recent advances and potential clinical applications

Cytokines and Molecular Therapy

Volumn 2, Issue 4, 1996, Pages 69-79

  Hallek, Michael ^a   Wendtner, Clemens Martin ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adeno assoclated virus; Clinical application; Gene therapy; Tissue specificity; Vector

Indexed keywords

SINGLE STRANDED DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; BETA THALASSEMIA; CHRONIC GRANULOMATOUS DISEASE; CYSTIC FIBROSIS; DNA PACKAGING; FANCONI ANEMIA; GAUCHER DISEASE; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METACHROMATIC LEUKODYSTROPHY; NONHODGKIN LYMPHOMA; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SOMATIC CELL GENETICS; VIRUS RECOMBINANT;

ANEMIA; BETA-THALASSEMIA; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC DISEASES, INBORN; GENETIC VECTORS; GRANULOMATOUS DISEASE, CHRONIC; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS;

EID: 0029821717     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Marshall EM, Gene therapy's growing pains. Science (1995) 269: 1050-5.
2. Flotte TR, Carter BJ, Adeno-associated virus vectors for gene therapy. Gene Ther (1995) 2: 357-62.
3. Kotin R, Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene 77zer(1994) 5:793-801.
4. Berns KI, Parvovirus replication. Microbiol Rev (1990) 54: 316-29.
5. Berns KI, Parvoviridae and their replication. In: Fundamental virology (ed BN Fields, DM Knipe) 817-37. Raven Press, New York, 1991.
6. Carter BJ, Adeno-associated virus vectors. Curr Opin Biotech (1992) 3: 533-9.
7. Muzyczka N, Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol (1992) 158: 97-129.
8. Samulski RJ, Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Genet Dev (1993) 3: 74-80.
9. Blacklow NR, Adeno-associated viruses of humans. In: Parvovimses and human disease (ed J Pattison) 165-74. CRC Press, Boca Raton, FL, 1988.
10. Blacklow NR, Hoggan MD, Sereno MS et al A seroepidemiologic study of adenovirus-associated virus infections in infants and children. Am J Epidemiol(\91\) 94: 359-66.
11. Blacklow NR, Hoggan MD, Kapikian AZ et al Epidemiology of adeno-associated virus infection in a nursery population. Am J Epidemiol (1968) 89: 368-78.
12. Hermonat PL, The adeno-associated virus Rep78 gene inhibits cellular transformation by bovine papilloma virus. Virology (1989) 172: 253-61.
13. Mayor HD, Houlditch GS, Mumford DM, Influence of adeno-associated virus on adenovirus-induced tumors in hamsters. Nature (1973) 241: 44-6.
14. Khlief SN, Myers T, Carter BJ, Trempe JP, Inhibition of cellular transformation by the adenoassociated virus rep gene. Virology (1991) 181: 738-41.
15. Buller RML, Janik JE, Sebring ED, Rose JA, Herpes simplex virus type I and II completely help adeno-virus associated virus replication. J Virol (1981) 40: 241-7.
16. McPherson RA, Rosenthal LJ, Rose JA, Human cytomegalovirus completely helps adeno-associated virus replication. Virology (1985) 147: 217-22.
17. Im D-S, Muzyczka N, The AAV origin binding protein REP68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell (1990) 61: 447-57.
18. Chiorini JA, Weitzman MD, Owens RA et al Biologically active rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli.J Fzro/(1994) 68: 797-804.
19. Weitzman MD, Kyöstiö SRM, Kotin RM, Owens RA, Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc NatlAcad Sei USA (1994) 91:5808-12.
20. Samulski RJ, Chang L-S, Shenk T, Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Fzro/(1989) 63:3822-8.
21. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N, Adeno-associated virus gene transduction vectors: analysis of proviral structures. J Virol (1988) 62: 1963-73.
22. Mizukami H, Muramatsu S, Young NS, Brown KF, Adeno-associated virus type 2 binds to a 150 kilodalton cell membrane glycoprotein (abst). Blood (1995) 86 (Suppl 1): 240a.
23. Hermonat PL, Muzyczka N, Use of adeno-associated virus as mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sei USA (1984) 81: 6466-70.
24. Flotte TR, Afione SA, Conrad G et al Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sei USA (1993) 90: 10 613-17.
25. Walsh CE, Liu JM, Xiao X et al Regulated high level expression of a human -y-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sei USA (1992) 89: 7257-61.
26. Chiorini JA, Wendtner CM, Urcelay E et al Highefficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene 77zer(1995) 6: 1531-41.
27. Podsakoff G, Wong KJ, Chatterjee S, Efficient gene transfer into non-dividing cells by adeno-associated virus-based vectors. J Virol (1994) 68: 5656-66.
28. Goodman X, Xiao X, Donahue RE et al Recombinant adeno-associated virus mediated gene transfer into hematopoietic progenitor cells. Blood (1994) 84:1492-1500.
29. Kaplitt MG, Leone P, Samulski RJ et al Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet (1994) 8: 148-54.
30. Samulski RJ, Berns KI, Tan M, Muzyczka N, Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sei USA (1982) 79: 2077-81.
31. Samulski RJ, Chang L-S, Shenk T, A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 61: 3096-101.
32. Nahreini P, Woody MJ, Zhou SZ, Srivastava A, Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene (1993) 124: 257-62.
33. Mamounas M, Leavitt M, Yu M, Wong-Staal F, Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Ther (1995) 2: 429-32.
34. Mendelson E, Smith MG, Miller IL, Carter BJ, Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector. Virology (1988) 166: 612-15.
35. Caillet-Fauquet P, Perros M, Brandenburger A et al Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding nonstructural proteins. EMBOJ (1990) 9: 2989-95.
36. Yang Q, Chen F, Trempe JP, Characterization of cell lines that inducibly express the adeno-associated virus rep proteins. J Virol (1994) 68: 4847-56.
37. Vincent KA, Moore GK, Haigwood NL, Replication and packaging of HIV envelope genes in a novel adeno-associated virus vector system. In: Vaccines 90 (ed F Brown, RM Chanock, HS Ginsberg), 353-9. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1990.
38. Trempe JP, Yang Q, Characterization of a cell line that expresses the AAV replication proteins (abst). In: Proceedings of 5th Parvovims Workshop, Crystal River, FL, 1993. 4
39. Kölscher C, Hörer M, Kleinschmidt JA et al_C,elF lines inducibly expressing the adeno-associatéd virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J Virol (1994) 68: 7169-77.
40. Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR, Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther (1995) 6: 1329-41.
41. Lebkowski JS, McNally MA, Okarma TB, Production of recombinant adeno-associated virus vectors. US Patent (1992) 5: 414.
42. Flotte RT, Barraza-Ortiz X, Solow R et al An improved system for packaging recombinant adenoassociated virus vectors capable of in vivo transduction. Gene Ther (1995) 2: 29-37.
43. Beaton A, Palumbo P, Berns KI, Expression from the adeno-associated virus p5 and p!9 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 63: 4450-4.
44. Colosi P, Elliger S, Ellsiger C, Kurtzman G, AAV vectors can be efficiently produced without helper virus (abst). Blood (1995) 86 (Suppl 1): 627a.
45. Ponnazhagan S, Wang X-S, Srivastava A, Yoder MC, Adeno-associated virus 2-mediated gene transfer and expression in murine hematopoietic progenitor cells in vivo (abst). Blood (1995) 86 (Suppl 1): 240a.
46. Flotte TR, Conrad C, Reynolds T et al Preclinical evaluation of AAV vectors expressing the human CFTR cDNA (abst). J Cell Biochem (1995) 21 A: 364.
47. Fisher KJ, Gao G-P, Weitzman MD et al Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J Virol ( 1996) 70: 520-32.
48. Russell DW, Miller AD, Alexander IE, Adenoassociated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sei USA (1995) 91: 8915-19.
49. Zhou SZ, Broxmeyer HE, Cooper S et al Adenoassociated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol (1993) 21: 928-33.
50. Miller JL, Donahue RE, Sellers SE et al Recombinant adeno-associated virus (rAAV)mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc NatlAcadSci USA (1994) 91: 10183-7.
51. Walsh CE, Liu JM, Miller JL et al Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med (1993) 204: 289-300.
52. Perrine SP, Cinder G, Faller GV et al A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. NEnglJ Med (1993) 328: 81-6.
53. Weatherall DJ, Clegg JB, The thalassemia syndromes. } Blackwell, London, 1981.
54. Einerhand MPW, Antoniou M, Zolotukhin S et al Regulated high-level human β-globin gene expression in erythroid cells following recombinarit adeno-associated virus-mediated gene transfer. Gene Tlier (1995) 2: 336-43.
55. Walsh CE, Nienhuis AW, Samulski RJ et al Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adenoassociated virus vector. J Clin Invest (1994) 94: 1440-8.
56. Thrasher AJ, Ahvis Md, Casimir CM et al Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase. Gene Tlier (1995) 2: 481-5.
57. Kay MA, Woo SLC, Gene therapy for metabolic disorders. Trends Genet (1994) 10: 253-7.
58. Wei J-F, Wei F-S, Samulski RJ, Barranger JA, Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector. Gene Ther (1994) 1: 261-8.
59. Boat TF, Welsh MJ, Beaudet al Cystic fibrosis. In: The metabolic basis of inherited disease (ed CR Scriver, AL Beaudet, WS Sly, D Valle) 2649-80. McGrawHill, New York, 1989.
60. Riordan JR, Rommens JM, Kerem B-S et al Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 245: 1066-73.
61. Riordan JR, The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol (1993) 55: 609-30.
62. Alton EWFW, Geddes DM, Gene therapy for cystic fibrosis: a clinical perspective. Gene Ther (1995) 2: 88-95.
63. Flotte TR, Solow R, Owens RA et al Gene expression from adeno-associated virus vectors in airway epithelial cells. Am J Respir Cell Mol Biol (1992) 7: 349-56.
64. Flotte TR, Afione SA, Solow R et al Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter, jf Biol Chem (1993) 268: 3781-90.
65. Egan M, Flotte T, Afione S et a\, Defective regulation of outwardly rectifying Cl" channels by protein kinase A corrected by insertion of CFTR. Nature (1992) 358: 581-4.
66. Zeitlin PL, Chu S, Conrad C et al Alveolar stem cell transduction by an adeno-associated viral vector. Gene Ther (1995) 2: 623-31.
67. Culver KW, Blaese RM, Gene therapy for cancer. Trends Genet (1994) 10: 174-8.
68. Wendtner'-CM, Mangold E, Braun-Falco M et al Efficient, stable and functional expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in human lymphoma cells by an improved adeno-associated virus (AAV) vector (abst). jf Mol Med (1995) 73: B13-14.
69. Donahue RE, Kessler SW, Bodine D et al Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 176: 1125-35.
70. Flotte TR, Afione SA, Zeitlin PL, Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol (1994) 11: 517-21.
71. Kotin RM, Siniscalco M, Samulski RJ et al Sitespecific integration by adeno-associated virus. Proc NatlAcadSci USA (1990) 87: 2211-15.
72. Kotin RM, Menninger JC, Ward DC, Berns KI, Mapping and direct visualisation of region-specific viral DNA integration site on chromosome 19ql3qter. Genomics (1991) 10: 831-4.
73. Natsoulis G, Surosky R, Godwin S, et al A system for specifically targeting genes to chromosome 19 (abst). Blood (1995) 86 (Suppl 1): 236a.
74. Flotte RT, Barraza-Ortiz X, Solow R et al An improved system for packaging recombinant adenoassociated virus vectors capable of in vivo transduction. Gene Ther (1995) 2: 29-37.
75. Flotte TR, Prospects for virus-based gene therapy for cystic fibrosis. J Bioenerg Biomembr (1993) 25: 37-42.
76. Miller JL, Walsh CE, Samulski RJ et al Transfer and expression of the human y globin gene in purified hematopoietic progenitor cells from Rhesus bone marrow using a recombinant adeno-associated virus (rAAV) vector (abst). In: Proceedings of 5th Parvovims Workshop, Crystal River, FL, 1993.
77. Muro-Cacho CA, Samulski RJ, Kaplan D, Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immitnother (1992) 11: 231-37.
78. Lebkowski JS, McNally MM, Okarma TB, Lerch LB, Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol (1988) 8: 3988-96.
79. Ponnazhagan S, Nallari ML, Srivastava A, Suppression of human a-globin gene expression mediated by the recombinant adeno-associated virus 2-based vectors. J Exp Med (1994) 179: 733-8.
80. Luo F, Zhou SZ, Cooper S et al Adeno-associated virus 2-mediated transfer and functional expression of a gene encoding the human granulocyte-macrophage colony-stimulating (abst). Blood (1993) 82 (Suppl 1): 303a.
81. Haibert CL, Alexander IE, Wolgamot GM, Miller AD, Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol( 1995) 69: 1473-9.
82. Chatterjee S, Johnson PR, Wong JKK, Dual-target inhibition of HIV-1 in vitro by means of an adenoassociated virus antisense vector. Science (1992) 258: 1485-8.
83. Philip R, Brunette E, Kilinski L et al Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol (1994) 14: 241118.